BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12688410)

  • 1. Effects of temocapril and olmesartan on myocardial sympathetic nervous activity and fatty acid metabolism in rats with chronic beta-adrenergic stimulation.
    Ido A; Hasebe N; Takeuchi T; Kikuchi K
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S133-7. PubMed ID: 12688410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.
    Iwamoto M; Hirohata S; Ogawa H; Ohtsuki T; Shinohata R; Miyoshi T; Hatipoglu FO; Kusachi S; Yamamoto K; Ninomiya Y
    Hypertens Res; 2010 Dec; 33(12):1305-11. PubMed ID: 20944640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice.
    Zhang GX; Ohmori K; Nagai Y; Fujisawa Y; Nishiyama A; Abe Y; Kimura S
    J Mol Cell Cardiol; 2007 Apr; 42(4):804-11. PubMed ID: 17350036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
    Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A
    J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.
    Takemoto M; Egashira K; Tomita H; Usui M; Okamoto H; Kitabatake A; Shimokawa H; Sueishi K; Takeshita A
    Hypertension; 1997 Dec; 30(6):1621-7. PubMed ID: 9403592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats.
    Ohnishi K; Murase M; Nakano D; Pelisch N; Hitomi H; Kobori H; Morimoto S; Mori H; Masaki T; Ohmori K; Kohno M; Ichihara A; Nishiyama A
    J Pharmacol Sci; 2013; 122(2):103-8. PubMed ID: 23698111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
    Zaman AK; Fujii S; Goto D; Furumoto T; Mishima T; Nakai Y; Dong J; Imagawa S; Sobel BE; Kitabatake A
    J Mol Cell Cardiol; 2004 Aug; 37(2):525-35. PubMed ID: 15276022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.
    Higashiura K; Ura N; Takada T; Li Y; Torii T; Togashi N; Takada M; Takizawa H; Shimamoto K
    Am J Hypertens; 2000 Mar; 13(3):290-7. PubMed ID: 10777034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model.
    Kim-Mitsuyama S; Izumi Y; Izumiya Y; Yoshida K; Yoshiyama M; Iwao H
    Hypertens Res; 2004 Oct; 27(10):771-9. PubMed ID: 15785013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
    Kusumoto K; Igata H; Ojima M; Tsuboi A; Imanishi M; Yamaguchi F; Sakamoto H; Kuroita T; Kawaguchi N; Nishigaki N; Nagaya H
    Eur J Pharmacol; 2011 Nov; 669(1-3):84-93. PubMed ID: 21816148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats.
    Kamide K; Rakugi H; Higaki J; Okamura A; Nagai M; Moriguchi K; Ohishi M; Satoh N; Tuck ML; Ogihara T
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):66-71. PubMed ID: 11824863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy.
    Nakamura T; Inoue T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H; Node K
    Am J Hypertens; 2007 Nov; 20(11):1195-201. PubMed ID: 17954367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW; Huang YW; Xia Q; Xu QW
    Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
    J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin AT1 receptor antagonist on volume overload-induced cardiac gene expression in rats.
    Kim S; Sada T; Mizuno M; Ikeda M; Yano M; Miura K; Yamanaka S; Koike H; Iwao H
    Hypertens Res; 1997 Jun; 20(2):133-42. PubMed ID: 9220278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity.
    Furuhashi M; Ura N; Takizawa H; Yoshida D; Moniwa N; Murakami H; Higashiura K; Shimamoto K
    J Hypertens; 2004 Oct; 22(10):1977-82. PubMed ID: 15361770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system modulates oxidative stress-induced endothelial cell apoptosis in rats.
    Akishita M; Nagai K; Xi H; Yu W; Sudoh N; Watanabe T; Ohara-Imaizumi M; Nagamatsu S; Kozaki K; Horiuchi M; Toba K
    Hypertension; 2005 Jun; 45(6):1188-93. PubMed ID: 15867141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.